Santé Cannabis

What Santé Cannabis does

Santé Cannabis is an independent medical cannabis clinic and clinical research organization (CRO) founded in 2014 and headquartered in Montreal, Quebec. The company operates a vertically integrated platform combining patient care, healthcare professional training, and clinical research. Its core offering is the medical cannabis clinic, which provides assessment, prescription, and ongoing follow-up care to Quebec residents with chronic pain, PTSD, anxiety, depression, cancer-related symptoms, and other qualifying conditions — consultations are covered by Quebec's public health insurance (RAMQ), so patients are not billed directly. The clinic has assessed 20,000+ patients cumulatively and is trusted by 7,500+ referring doctors in Quebec. A specialized veteran care service line provides direct billing to Veterans Affairs Canada through Medavie.

The company generates revenue through three primary streams: (1) research and CRO services for pharmaceutical, biotech, cannabis, and psychedelic companies; (2) healthcare professional training programs, including prescriber training, preceptorships, mentorship, a McGill University-affiliated Family Medicine residency elective, and international training; and (3) clinic development consulting. The research arm is Canada's first independently accredited cannabis CRO and holds four Cannabis Research Licenses from Health Canada. It operates a proprietary observational study protocol using targeted validated questionnaires, building a real-world evidence database covering 4,000+ patients. Technology infrastructure includes the Telus Health Medesync EMR system and community-based adaptive remote data collection methods.

In 2024, Santé Cannabis launched a Psychedelic-Assisted Therapy program in partnership with Refuge Psychology and began a 3-year, 3,000-patient Real-World Evidence Study supported by Aurora Cannabis, Tilray Medical, and Vectura Fertin Pharma. The company is expanding internationally through training and research partnerships in Colombia, Argentina, and Thailand, and sells training resources and mentorship through an online boutique. The leadership team includes co-founders Erin Prosk (MSc, President) and Dr. Michael Dworkind (Medical Director, 40+ years of palliative care expertise, McGill Associate Professor), supported by specialized clinical and research directors. The legal entity is 9307-6149 Québec Inc., and the company operates as a privately held, bootstrapped organization with no disclosed venture capital backing.

Name

Santé Cannabis

Legal name

9307-6149 Québec Inc.

Website

https://santecannabis.ca

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Santé Cannabis is a Montreal-based independent medical cannabis clinic and CRO, founded in 2014, providing patient assessments, healthcare professional training, and clinical research services across Quebec and internationally.

Ownership category

akta.pro rank

Product category

Medical Cannabis Clinical Services

NAICS

Health Care and Social Assistance (62)

SIC

Services-Health Services (8000)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

akta.pro secondary industry

Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

Keywords

• Medical cannabis clinic
• Clinical research services
• Healthcare professional training
• Cannabis CRO services
• Psychedelic-assisted therapy

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Services - Patient Consultations: Patient consultations are covered by RAMQ (Quebec public health insurance). There are no fees for patients with valid Quebec health cards.
2. Research Services: CRO and clinical trial services provided to pharmaceutical companies, biotech firms, cannabis companies, and psychedelic companies. Services include study design, regulatory support, clinical site services, and real-world data programs.
3. Training and Education Services: Training programs for healthcare professionals including prescriber training, preceptorships, mentorship, and educational materials. Revenue generated from training fees for non-affiliated practitioners and organizations.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Santé Cannabis is a medical cannabis clinic and clinical research organization that provides patient assessments, personalized treatment plans, and ongoing follow-up care for Quebec residents seeking medical cannabis therapy, including specialized veteran care and psychedelic-assisted therapy. Beyond clinical care, it offers healthcare professional training programs, clinic development consulting, and contract research organization (CRO) services including observational studies, clinical trials, and real-world evidence programs for pharmaceutical, biotech, cannabis, and psychedelic companies.

Product overview

Santé Cannabis is an independent medical cannabis clinic and clinical research organization established in 2014, operating a platform of integrated clinical, educational, and research services. Its core offering is the Medical Cannabis Clinic providing patient assessment, prescription, and follow-up care, supported by specialized Veteran Care Services and a 2024-launched Psychedelic-Assisted Therapy program. These clinical services are complemented by Medical Cannabis Training Services (prescriber programs, preceptorships, residency electives, international training) and a dedicated Clinic Development Services arm for partners. The research division operates as a CRO and clinical site, offering observational studies, clinical trials, and real-world evidence programs including a 3-year, 3,000-patient study launched in 2024. An online boutique sells training resources and mentorship sessions. Together, these products form a vertically integrated model from patient care to professional education to research — all anchored by the clinic as the primary platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Cannabis Clinic Medical cannabis clinic providing patient assessment, prescription, personalized treatment plans, and ongoing follow-up care for Quebec residents with chronic pain, PTSD, anxiety, depression, cancer symptoms, and other qualifying conditions. Operates since 2014 with over 20,000 patients served, accessible in-person at clinic sites and via telemedicine.
• Veteran Care Services
• Psychedelic-Assisted Therapy Program Psychedelic-Assisted Therapy program launched in 2024 providing supported access to psychedelic medicines through a multidisciplinary team at Santé Cannabis and partner Refuge Psychology, including psychotherapy and integration sessions. Targets patients with traumatic experiences, end-of-life distress, and treatment-resistant conditions.
• Medical Cannabis Training Services Suite of training programs for healthcare professionals including the Prescriber Training Program for Quebec-based doctors and nurse practitioners, clinical preceptorships, mentorship, a Family Medicine Residency Elective in partnership with McGill University, international training, and continuing medical education events. The organization has delivered 200+ continuing medical education events since 2014.
• Clinical Research and CRO Services Canada's first independently accredited cannabis Contract Research Organization (CRO) and clinical trial site, offering study design, regulatory services, clinical operations, real-world evidence programs, observational studies, and psychedelic medicines research for pharmaceutical, biotech, cannabis, and psychedelic company sponsors. Holds four Cannabis Research Licenses from Health Canada.
• 3-Year Real-World Evidence Study 3-year prospective real-world evidence study launched in October 2024 designed to follow 3,000 patients over 12 months, exploring personalized medical cannabis treatment outcomes including benefits, safety risks, medication substitution, and cost analysis. Supported by industry partners Aurora Cannabis, Tilray Medical, and Vectura Fertin Pharma.
• Clinic Development Services
• Online Boutique

Quantifiable outcome

• More than 20,000 patients assessed and supported since 2014
• +3 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

19 partnerships are on record, tiered flagship, core and minor.

• Aurora CannabisflagshipStrategic or Co-development Partner · 1 October 2024Industry partner supporting the 3-year Real-World Evidence Study. Part of the Real World Evidence Program Partners group supporting Santé Cannabis research initiatives.
• Tilray MedicalflagshipStrategic or Co-development Partner · 1 October 2024Industry partner supporting the 3-year Real-World Evidence Study. Part of the Real World Evidence Program Partners group supporting Santé Cannabis research initiatives.
• Vectura Fertin PharmaflagshipStrategic or Co-development Partner · 1 October 2024Industry partner supporting the 3-year Real-World Evidence Study focused on personalized medical cannabis treatment outcomes.
• McGill University (Allan Edwards Pain Management Unit)coreStrategic or Co-development PartnerSanté Cannabis is a recognized McGill University teaching site, operating Canada's first elective program for Family Medicine residents on medical cannabis for chronic pain and palliative care.
• BC CancercoreStrategic or Co-development PartnerClinical research partner. Involved in Canada's first national cannabis trial with BC Cancer.
• IGC PharmacoreStrategic or Co-development PartnerClinical research partner for cannabinoid-based medicines research.
• Credo SciencecoreStrategic or Co-development PartnerClinical research partner supporting medical cannabis research initiatives.
• AltasciencescoreStrategic or Co-development PartnerClinical research partner providing research services.
• AvicannacoreStrategic or Co-development PartnerClinical research partner for cannabinoid-based medicines research.
• Spectrum TherapeuticscoreChannel Partner/ Reseller/ DistributorMedical cannabis clinic partner - Licensed Seller providing medical cannabis products to patients.
• MyMedicoreChannel Partner/ Reseller/ DistributorMedical cannabis clinic partner - Licensed Seller providing medical cannabis products to patients.
• AQIC (Association québecoise interdisciplinaire de la douleur chronique)minorStrategic or Co-development PartnerIndustry partner representing chronic pain stakeholders.
• C3 Canadian Cannabis CouncilminorStrategic or Co-development PartnerIndustry association partner for Canadian cannabis industry advocacy.
• Association of Palliative Care of ColombiaminorStrategic or Co-development PartnerInternational partner for palliative care education and research collaboration.
• Colombian Association for the Study of PainminorStrategic or Co-development PartnerInternational partner for pain management education and research.
• Universidad Nacional De Rosario, ArgentinaminorStrategic or Co-development PartnerInternational academic partner for medical cannabis education and research.
• Thailand Association of Palliative CareminorStrategic or Co-development PartnerInternational partner for palliative care education and research collaboration.
• Sora CarecoreChannel Partner/ Reseller/ DistributorClinic partner for patients outside Quebec. Referrals sent to Sora Care for medical cannabis services in other provinces.
• Refuge PsychologycoreStrategic or Co-development PartnerPartner organization for the Psychedelic-Assisted Therapy program, providing multidisciplinary team of trained, experienced health professionals.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Canopy Growth: Major Canadian cannabis company with Spectrum Therapeutics medical division. Comparable as a broad incumbent with medical cannabis patient-facing services overlapping Santé Cannabis's clinical remit.
• Tilray: Major Canadian licensed producer of medical cannabis with a broader portfolio including branded medical products. Flagship RWE Study partner to Santé Cannabis and a broad incumbent across the cannabis value chain.
• Shoppers Drug Mart (Loblaw Companies): Canadian pharmacy chain operating a national medical cannabis program in partnership with licensed producers. Broad incumbent with patient-facing medical cannabis distribution that overlaps with Santé Cannabis's clinical channel.
• Aurora Cannabis: Large Canadian licensed producer with medical cannabis operations. Flagship partner supporting Santé Cannabis's 3-year RWE Study and a broad incumbent in cannabis clinical and product markets.

Emerging players

• Veriheal: Cannabis telehealth and patient-acquisition platform connecting patients to clinics and providers. Comparable as an emerging player in the medical cannabis patient-services ecosystem with similar telemedicine delivery.
• Field Trip Health: Operated psychedelic-assisted therapy clinics for mental health. Comparable as an emerging player in the psychedelic clinical services space intersecting with Santé Cannabis's new therapy program.
• Numinus: Canadian mental health company operating psychedelic-assisted therapy clinics and clinical research. Comparable via Santé Cannabis's 2024-launched Psychedelic-Assisted Therapy program and overlapping focus on treatment-resistant conditions.

Direct peers

• CannaWay Clinic: Canadian medical cannabis clinic providing patient assessments, treatment plans, and follow-up care. Directly comparable clinical model focused on medical cannabis consultations and ongoing patient support.
• Apollo Cannabis Clinics: Operates Canada's largest network of medical cannabis clinics, having cared for more than 100,000 patients. Co-founded by Dr. Danial Schecter, who is now Associate Director of Clinical Education at Santé Cannabis, making it the most directly comparable clinic operator.
• Verda Clinic: Canadian medical cannabis clinic providing physician-led assessments and personalized treatment plans. Closely comparable patient-care service model targeting similar chronic pain, mental health, and chronic-condition use cases.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/santecannabis
• Facebookfacebook.com/santecann

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Santé Cannabis